Akouos Total Non Current Liabilities 2011-2026 | AKUS

Annual Total Non Current Liabilities Akouos

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	12 M	72 M	28.1 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
72 M	12 M	37.4 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Alector ALEC	165 M	$ 2.13	-12.55 %	$ 219 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
BioCardia BCDA	1.3 M	$ 1.37	6.2 %	$ 29 M	USA
Black Diamond Therapeutics BDTX	7.69 M	$ 2.4	-2.83 %	$ 132 M	USA
BioLineRx Ltd. BLRX	8.22 M	$ 2.8	-1.06 %	$ 908 M	Israel
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
BioXcel Therapeutics BTAI	1.4 M	$ 1.64	-1.8 %	$ 4.16 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
BeyondSpring BYSI	37.6 M	$ 1.44	6.3 %	$ 58.1 M	USA
Cabaletta Bio CABA	43.9 M	$ 3.34	0.6 %	$ 3.9 M	USA
AbCellera Biologics ABCL	326 M	$ 3.7	2.49 %	$ 1.11 B	Canada
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Codexis CDXS	28.2 M	$ 1.05	3.47 %	$ 77.1 M	USA
Cerus Corporation CERS	58.1 M	$ 2.6	1.56 %	$ 480 M	USA
Certara CERT	482 M	$ 7.17	1.27 %	$ 1.15 B	USA
Cullinan Management CGEM	277 M	$ 15.91	2.65 %	$ 931 M	USA
Compugen Ltd. CGEN	39.9 M	$ 2.28	25.97 %	$ 204 M	Israel
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Coherus BioSciences CHRS	189 M	$ 1.66	-0.9 %	$ 156 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	109 M	$ 3.88	-	$ 116 M	France
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Cocrystal Pharma COCP	1.5 M	$ 1.02	-0.97 %	$ 10.4 M	USA
Aptose Biosciences APTO	10.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Collegium Pharmaceutical COLL	17.1 M	$ 42.0	0.79 %	$ 1.33 B	USA
Corcept Therapeutics Incorporated CORT	2.29 M	$ 35.61	-0.25 %	$ 3.7 B	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA